Weight gain that comes on gradually and then seems to accelerate. Belly fat that won’t budge no matter how many diets you try. A persistent feeling that your body is storing everything instead of burning it — and the gnawing suspicion that the problem is biological, not just behavioral. For millions of people, this is not a temporary plateau or a motivation problem. It is the lived experience of a metabolic cycle that connects insulin resistance and obesity in a self-reinforcing loop that calorie restriction alone cannot reliably break. When you are inside that cycle, it can feel like your body is working against you. In a very real biochemical sense, it is.
The relationship between insulin resistance and obesity is bidirectional — each condition worsens the other, and most standard approaches to weight management fail to account for both. People who have struggled with weight for years are often told to eat less and exercise more, which is advice that ignores the hormonal and metabolic barriers that make fat loss genuinely harder when insulin resistance is present. When the underlying metabolic dysfunction is not identified and treated, weight loss efforts produce frustration instead of results. Many patients don’t learn about insulin resistance until they are already dealing with prediabetes or type 2 diabetes — years after the metabolic problem first developed.
SustainMD was built specifically to address this gap. Dr. Allison Barbee, a board-certified physician with advanced training in both internal medicine and obesity medicine, evaluates the metabolic root causes of weight gain — including insulin resistance — that often go undetected in standard care settings. Through telehealth appointments available in North Carolina, California, Florida, and Maine, she provides the kind of thorough, personalized metabolic evaluation that can finally explain what is driving the weight and what can actually be done about it.
Understanding Insulin Resistance
Insulin is a hormone produced by the pancreas that acts like a key — it unlocks cells so they can absorb glucose from the bloodstream and use it for energy. Insulin resistance occurs when cells stop responding normally to this signal. The pancreas compensates by producing more insulin, but over time, even elevated insulin cannot keep blood sugar at optimal levels. The result is a state of chronically high insulin combined with rising blood glucose — a pattern that has profound effects on fat storage, appetite, and metabolism.
Insulin resistance develops gradually over time and is influenced by a combination of genetic predisposition, dietary patterns, physical inactivity, sleep disruption, and chronic stress. Most people develop insulin resistance years before any standard blood test reveals a problem, because fasting glucose — the marker most commonly used in routine labs — is one of the last values to become abnormal. Fasting insulin and HOMA-IR calculations are far more sensitive early indicators, but they are rarely included in standard screening.
How Insulin Resistance Drives Weight Gain
The connection between insulin resistance and weight gain is not simply that overweight people tend to develop insulin resistance. The relationship runs the other direction as well — insulin resistance itself makes weight gain more likely and weight loss significantly harder. Here is how:
- Elevated insulin actively promotes fat storage: Insulin is a fat-storage hormone. When insulin levels are chronically elevated because cells are resistant to its effects, the body is receiving a constant signal to store energy as fat rather than burn it. This makes fat accumulation more efficient and fat mobilization less so — even in a caloric deficit.
- Fat burning is suppressed: High insulin levels directly inhibit lipolysis — the process by which fat is broken down and released from fat cells for use as fuel. When insulin is chronically elevated, the body has difficulty accessing stored fat for energy, regardless of food intake.
- Hunger signals are dysregulated: Insulin resistance is closely tied to leptin resistance, a condition in which the brain’s fullness signal becomes blunted. This means that people with insulin resistance may feel hungry more often and feel less satisfied after eating — making caloric restriction feel physically difficult rather than just a matter of willpower.
- Visceral fat accumulation creates a feedback loop: Visceral fat — the deep abdominal fat surrounding organs — is particularly metabolically active. It releases inflammatory signals and free fatty acids that worsen insulin resistance further, creating a self-reinforcing cycle in which insulin resistance drives more visceral fat gain, which worsens insulin resistance.
How Obesity Worsens Insulin Resistance
The cycle runs in both directions. Excess body fat — particularly visceral fat — is one of the most potent drivers of insulin resistance. Fat tissue, especially when inflamed, produces cytokines and adipokines that disrupt insulin signaling at the cellular level. The more visceral fat accumulates, the more severe the insulin resistance tends to become.
This creates a metabolic trap: insulin resistance makes weight gain more likely by promoting fat storage and suppressing fat burning, and obesity worsens insulin resistance by increasing the volume and inflammatory activity of visceral fat. Breaking this cycle requires addressing both sides simultaneously — which is why treating obesity without also correcting insulin resistance rarely produces lasting results.
The Role of the Liver
The liver plays a central role in this cycle. When insulin resistance develops, the liver continues to produce glucose even when blood sugar is already elevated — a process that should normally be suppressed by insulin signaling. At the same time, excess fat begins to accumulate in the liver (non-alcoholic fatty liver disease, or NAFLD), which further impairs insulin signaling and perpetuates the cycle. Research suggests that a meaningful portion of people with obesity have some degree of hepatic insulin resistance, even if liver enzymes appear normal on standard panels.
Standard Testing Often Misses the Early Cycle
One of the most significant problems in addressing this cycle is that standard care often waits too long to detect it. The following patterns are common but preventable with earlier intervention:
- Fasting glucose is tested, but fasting insulin is not: Glucose can remain in the normal range for years while insulin is chronically elevated and compensating for worsening resistance. By the time glucose rises, the metabolic cycle has been active for a long time.
- HbA1c is used to diagnose diabetes but misses prediabetes in many patients: Research suggests that standard HbA1c cutoffs miss a significant proportion of people with clinically meaningful insulin resistance who would benefit from early metabolic intervention.
- Waist circumference and visceral fat are underutilized: BMI alone is an inadequate predictor of metabolic risk. Waist-to-height ratio and direct assessment of fat distribution patterns provide much more clinically relevant information about insulin resistance risk.
Breaking the Cycle: How Metabolic Treatment Works
Effective treatment of the insulin resistance-obesity cycle requires a multi-pronged approach that addresses both the hormonal environment and the behavioral factors that maintain it. Research supports the following strategies:
Dietary restructuring is often the most powerful initial lever. Reducing refined carbohydrates and added sugars reduces the glycemic load that drives insulin spikes. Increasing protein and fiber improves satiety, reduces ghrelin, and supports lean mass preservation during weight loss. Some patients do well with time-restricted eating patterns that allow extended overnight periods of low insulin, creating windows when fat burning can occur.
Physical activity improves insulin sensitivity through multiple mechanisms — it increases glucose transporter activity in muscle cells, reduces visceral fat accumulation, and improves mitochondrial function. Even modest amounts of regular movement produce measurable improvements in insulin sensitivity in most patients.
In patients with significant insulin resistance, medications may be appropriate. GLP-1 receptor agonists such as semaglutide and tirzepatide address both insulin resistance and appetite regulation, and research suggests they produce meaningful improvements in metabolic markers beyond what lifestyle changes alone can achieve for many patients. Metformin remains a well-established first-line option for improving insulin sensitivity in appropriate candidates.
Conclusion
Insulin resistance and obesity form one of the most consequential metabolic cycles in modern medicine — and one of the most commonly missed. The connection between the two is not coincidental or superficial. It is a bidirectional, self-reinforcing biological loop that requires targeted metabolic evaluation and treatment to break. If your weight has been resistant to all your efforts, if you carry weight primarily in your abdomen, or if you suspect your body is doing something different than it should, a metabolic evaluation focused on insulin resistance may be the most important step toward a lasting answer. Dr. Allison Barbee at SustainMD is here to help you understand and address the actual root cause.
| Medical DisclaimerThe information provided in this article is for educational purposes only and is not intended as medical advice. Every patient’s situation is different, and treatment recommendations vary based on individual health history, lab results, and clinical evaluation. Always consult a qualified healthcare professional before starting, changing, or stopping any treatment or health program. |
Frequently Asked Questions
1. Does insulin resistance always cause obesity?
Not always, but it significantly increases the risk. Insulin resistance promotes fat storage, suppresses fat burning, and disrupts hunger signals — all of which make weight gain more likely and weight loss more difficult over time.
2. Can I have insulin resistance even if I’m not diabetic?
Yes. Insulin resistance is a metabolic condition that typically precedes diabetes by many years. Many people with normal blood glucose levels have significant insulin resistance that is only detectable through fasting insulin and HOMA-IR testing.
3. What is the best way to test for insulin resistance?
Fasting insulin combined with fasting glucose allows calculation of HOMA-IR, which is the most practical clinical measure of insulin resistance. Standard fasting glucose or HbA1c alone are insufficient to detect insulin resistance in its early stages.
4. Can insulin resistance be reversed?
In many cases, yes. Research suggests that significant improvements in insulin sensitivity are achievable through dietary changes, regular physical activity, weight loss, improved sleep, and in some cases medication. The degree of reversal depends on individual factors and how long the condition has been present.
5. What foods should I avoid with insulin resistance?
Research suggests limiting refined carbohydrates, added sugars, sugary beverages, and highly processed foods — all of which trigger rapid insulin spikes. Talk to your physician about a dietary plan tailored to your specific metabolic profile.
6. Are GLP-1 medications appropriate for insulin resistance without diabetes?
GLP-1 receptor agonists have demonstrated significant metabolic benefits including improved insulin sensitivity, in patients across a range of conditions. Whether they are appropriate for you depends on your clinical picture. Talk to your physician about current obesity medicine guidelines and your individual situation.
7. How does belly fat connect to insulin resistance?
Visceral belly fat releases inflammatory compounds and free fatty acids that directly impair insulin signaling at the cellular level. The relationship is bidirectional — insulin resistance promotes visceral fat accumulation, and visceral fat worsens insulin resistance.
8. Does exercise help with insulin resistance?
Yes. Both aerobic exercise and resistance training improve insulin sensitivity through different mechanisms. Regular physical activity — even walking for 30 minutes most days — produces measurable improvements in insulin sensitivity in most patients.
9. How long does it take to improve insulin resistance?
With consistent dietary and lifestyle changes, meaningful improvements in insulin sensitivity are often detectable within 4 to 12 weeks. More significant improvements typically occur over several months with sustained effort and appropriate physician guidance.
10. Is SustainMD available for patients outside major metro areas?
Yes. SustainMD provides telehealth care for patients in North Carolina, California, Florida, and Maine — including rural and suburban areas — with no in-person visits required.
